Wakamoto Pharm 1H Group Net Loss Estimate 122.00M Yen 4512 JP
Wakamoto Pharm (4512) revised first-half group earnings estimates for the period to Sept. 30. Figures other than earnings per share are in millions of yen.
================================================================================
Operating Current Net Earnings
Revenue Profit Profit Income Per Share ================================================================================ First-Half Estimates 4737.00 -350.00 -219.00 -122.00 -3.51 Previous Estimates 4680.00 -570.00 -490.00 -290.00 -8.33 Year-Earlier Period 4638.00 -633.00 -540.00 -372.00 -10.81 ================================================================================
Page forward for parent information...
Parent Information ================================================================================
Operating Current Net Earnings
Revenue Profit Profit Income Per Share ================================================================================ First-Half Estimates 4716.00 -355.00 -223.00 -21.00 -0.60 Previous Estimates 4660.00 -575.00 -495.00 -190.00 -5.46 Year-Earlier Period 4617.00 -651.00 -550.00 -379.00 -11.01 ================================================================================
To contact the editor responsible for this story: Teo Chian Wei at +81-3-3201-3623 or cwteo@bloomberg.net
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.